-
FSHW Egg Xanthine Oxidase Inhibition Peptide Identification: Virtual Hydrolysis, Molecular Docking, and In Vitro Activity Evaluation
Time of Update: 2022-11-26
Check out the article The purpose of this study was to screen the xanthine oxidase (XO) inhibitory peptides from egg white proteins through virtual hydrolysis, in vitro activity validation, and molecular docking.
-
Neurology: spatial navigation in dementia-free memory clinics and its relationship to biomarkers and future dementia
Time of Update: 2022-10-31
Impaired spatial navigation is associated with transformation to dementia at 2 and 4 years and is associated with key cerebrospinal fluid and MRI biomarkers of AD and neurodegenerative diseases in patients with SCD and MCI.
-
First to be confirmed: an epigenetic drug EZH2 inhibitor that treats bladder cancer by activating the immune system
Time of Update: 2022-10-21
The study is the first to confirm that Tazemetostat, an epigenetic drug currently used to treat lymphoma and sarcoma, is able to suppress bladder cancer by activating the immune system。 The research team has initiated human clinical trials for advanced bladder cancer.
-
What about nocturnal enuresis in refractory children? Take a look at this study by foreign scholars
Time of Update: 2022-10-13
Fig. 1 Number of days of nocturia in two groups of patients at different time pointsconclusionAs a selective serotonin reuptake inhibitor (SSRI), fluoxetine is a safe and effective treatment regimen for refractory PMNE in children and adolescents with a good initial response.
-
What happened to these 18As who were once shrouded in halo and now fell into the abyss of "broken net
Time of Update: 2022-08-15
The cold winter of innovative medicines came so quickly, it was unpredictable . The reasons are complicated, but one thing is very clear. The innovative drugs at the current node, both macro and micr
-
This track has become a new blue ocean market for medicine, and local pharmaceutical companies are actively deploying
Time of Update: 2022-08-10
[Pharmaceutical Network Market Analysis] On May 18, Zhongsheng Pharmaceutical announced that its subsidiary Chia Tai Tianqing signed an agreement with Symhogen A/S, a wholly-owned subsidiary of Servi
-
WHO strongly recommends Pfizer's Paxlovid, but global demand for Paxlovid is declining
Time of Update: 2022-06-05
Recently, the World Health Organization (WHO) updated its COVID-19 treatment guidelines, strongly recommending that Pfizer's new crown oral antiviral drug Paxlovid be used to treat mild and poisoned COVID-19 patients .
-
The market value has evaporated by 400 billion
Time of Update: 2022-05-12
Some people gloat at misfortune and think that the valuation bubble can be squeezed again, and the 35 times price-earnings ratio is still too high; Some people are downcast, thinking that Hengrui Medicine can no longer afford the name of the carrier of innovative drug research and development; Some people are gearing up, preparing to enter the game at the bottom to enjoy the benefits of the fisherman .
-
J Intern Med: New coronavirus variant Omicron has new symptoms-acute swallowing pain
Time of Update: 2022-04-18
COVID-19 ManagementThis is a single-center retrospective case study recruiting patients with COVID-19 who presented to the Ear, Nose and Throat Emergency Department (ENT ED) between January 1 and January 23, 2022 with clinical symptoms of acute dysphagia, severe sore throat, and fever.
-
PNAS: Previously little-known protein involved in metabolic pathway required for cancer cell survival
Time of Update: 2022-01-24
But now that its important role in AML cells has been discovered, Polyanskaya said, "Other researchers can use this system, tweak some other things, and really try and pinpoint the exact pathway .
-
Can wolfberry be eaten for a long time? Will there be side effects if I eat too much
Time of Update: 2021-12-26
Many people in the past said that it can produce essence and nourish qi, remove yin deficiency and internal heat and improve eyesight.
Therefore, regular consumption of wolfberry can nourish the liver, nourish the kidneys, nourish the lungs, invigorate deficiency and essence, clear away heat and improve eyesight.
-
Notice on Public Solicitation of "Guiding Principles for Evaluation of Immune-Related Adverse Events in Anti-tumor Therapy (Draft for Comment
Time of Update: 2021-12-05
pdf 2 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Comment)" feedback form.
docx2 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Comment)" feedback form.
-
A cancer-targeted drug can reverse symptoms in Alzheimer's disease mice
Time of Update: 2021-10-09
Mice with Alzheimer's disease received axitinib treatment, the blood vessels and other disease markers in the brain decreased, and also performed very well in learning and memory tests .
-
How to deal with gastrointestinal bleeding
Time of Update: 2021-10-01
Upper gastrointestinal bleeding refers to bleeding in the esophagus, stomach, duodenum, upper jejunum, pancreatic duct and bile duct above the suspensory ligament of the duodenum .
Quickly check the guide information reference in the catalogue: [1 ]Rodrigues A, et al.
-
Merck and Alpine collaborate on immuno-oncology research to evaluate ALPN-202 combined with Keytruda
Time of Update: 2021-08-07
CompileriverRecently, clinical-stage immunotherapy company Alpine Immune Sciences has reached a cooperation agreement with Merck to evaluate the effectiveness and safety of Alpine’s checkpoint and Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) in the treatment of cancer .
